Edwards Lifesciences
772 hedge funds and large institutions have $19.6B invested in Edwards Lifesciences in 2017 Q4 according to their latest regulatory filings, with 113 funds opening new positions, 267 increasing their positions, 273 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% less call options, than puts
Call options by funds: $105M | Put options by funds: $105M
2% less repeat investments, than reductions
Existing positions increased: 267 | Existing positions reduced: 273
4.47% less ownership
Funds ownership: 250.94% → 246.47% (-4.5%)
Holders
772
Holding in Top 10
13
Calls
$105M
Puts
$105M
Top Buyers
| 1 | +$268M | |
| 2 | +$96.5M | |
| 3 | +$86M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$76.1M |
| 5 |
Two Sigma Investments
New York
|
+$66.3M |
Top Sellers
| 1 | -$146M | |
| 2 | -$122M | |
| 3 | -$108M | |
| 4 |
Renaissance Technologies
New York
|
-$106M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$76.6M |